Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib and Letrozole in Postmenopausal ER+ Metastatic Breast Cancer
NCT00634634Phase 2Completed
- Sponsor
- Rutgers University
- Start
- Aug 2008
- Primary completion
- Apr 2019
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in breast cancer, sponsored by Rutgers University. Started Aug 2008; status: completed.
02
Drugs
sorafenib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00634634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00634634.